| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |